Kawasumi Laboratories, Incorporated announced consolidated earnings results for the year ended March 31, 2018. For the year, the company reported net sales of ¥25,437 million against ¥24,726 million a year ago. Operating profit was ¥687 million against ¥923 million a year ago. Ordinary profit was ¥788 million against ¥1,023 million a year ago. Profit attributable to owners of parent was ¥440 million or ¥20.18 per basic share against ¥1,116 million or ¥51.16 per basic share a year ago. Cash flows from operating activities were ¥2,760 million against ¥2,947 million a year ago. Profit before income taxes was ¥733 million against ¥1,017 million a year ago. Purchase of property, plant and equipment was ¥657 million against ¥2,072 million a year ago. Purchase of intangible assets was ¥60 million against ¥381 million a year ago.

The company provided consolidated earnings guidance for the year ending March 31, 2019. For the full year, the company expects net sales of ¥23,000 million, operating loss of ¥300 million, ordinary loss of ¥200 million and loss attributable to owners of parent of ¥1,700 million or ¥77.93 per share.

The company announced dividend of ¥7.50.00 per share for the year ended March 31, 2018 against ¥10.00 per share paid for the same period a year ago. The dividend is payable on June 22, 2018.

The company provided dividend guidance for the second quarter of fiscal 2019 and for the year ending March 31, 2019. For the second quarter of fiscal 2018, the company expects to pay dividend of ¥7.50 per share against a paid dividend of ¥7.50 per share for the same period a year ago.

For the year ending March 31, 2019, the company expects to pay dividend of ¥7.50 per share against ¥7.50.00 per share announced for the same period a year ago.